Jarle Jortveit

Author information from the last article

Hjerteseksjonen

Sørlandet sykehus Arendal

Forfatterbidrag: utforming/design, datainnsamling, tolking av data, revisjon av manuset og godkjenning av innsendt manus.

Jarle Jortveit er ph.d., spesialist i indremedisin og i hjertesykdommer, forsker og overlege ved Hjerteseksjonen, Sørlandet sykehus Arendal.

Articles by Jarle Jortveit

Gender differences in the assessment and treatment of myocardial infarction

Jarle Jortveit,
Ragna Elise Støre Govatsmark,
Jørund Langørgen,
Torstein Hole,
Jan Mannsverk,
Siv Olsen,
Cecilie Risøe,
Sigrun Halvorsen

23.08.2016: Each year, some 13 000 Norwegians are admitted to Norwegian hospitals with acute myocardial infarction (1). Several studies have shown that women may have less clear symptoms and clinical findings, wait longer for treatment, less frequently undergo invasive assessment and receive less secondary...

Myocardial infarction in Norway in 2013

Jarle Jortveit,
Ragna Elise Støre Govatsmark,
Tormod Aarlott Digre,
Cecilie Risøe,
Torstein Hole,
Jan Mannsverk,
Stig Arild Slørdahl,
Sigrun Halvorsen

14.10.2014: Cardiovascular diseases constitute the most common cause of hospitalisation in Norway (1). Although the mortality rate for these diseases has fallen in Norway in recent years, ischaemic heart disease is still one of the most common causes of death (2). Up until 2012 there was no national quality...

Are the guidelines for treatment of myocardial infarction complied with?

Jarle Jortveit,
Bjørnar Grenne,
Michael Uchto,
Thomas Dahlslett,
Liv Fosse,
Pål Gunnes

25.02.2014: Each year, 12 – 15 000 Norwegians suffer myocardial infarction (1). In the past, the treatment strategy on suspicion of acute myocardial infarction has depended mainly on whether the ECG shows ST elevation or not. The benefit of early revascularisation by means of percutaneous coronary intervention...